Billion dollar baby

Grail dwarfs the private diagnostics space with a planned $1B series B round

With what could be more than a $1 billion B round in the works, cancer screening company Grail Inc. is on track to set a new private financing record. The round is expected to close this quarter with participation from undisclosed private and

Read the full 431 word article

User Sign In